FDA allows marketing of first-of-kind computerized cognitive tests to help assess cognitive skills after a head injury

The U.S. Food and Drug Administration today (Aug 22) permitted marketing of two new devices to assess a patient’s cognitive function immediately after a suspected brain injury or concussion. The Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) and ImPACT Pediatric are the first medical devices permitted for marketing that are intended to assess cognitive function […]

Read the whole article on Science Blog

More from Science Blog